Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human PCDHB16 ELISA Kit (AC3501)
Cat.#: ASET-2090
Specifications
Description Human PCDHB16 ELISA Kit allows for the in vitro quantitative determination of human PCDHB16 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1157 Canine Syndecan-1 ELISA Kit (AC2568) Quantitative inquiry ASET-1251 Human PICALM ELISA Kit (AC2662) Quantitative inquiry ASET-1580 Human ANGPTL7 ELISA Kit (AC2991) Quantitative inquiry ASET-1485 Rat Vaspin ELISA Kit (AC2896) Quantitative inquiry ASET-2462 Human Zyxin ELISA Kit (AC3873) Quantitative inquiry ASET-2447 Human Neuropilin 1 ELISA Kit (AC3858) Quantitative inquiry ASET-2314 Human TNF Receptor II ELISA Kit (AC3725) Quantitative inquiry ASET-1795 Guinea Pig beta Nerve Growth Factor ELISA Kit (AC3206) Quantitative inquiry ASET-1142 Human SHANK3 ELISA Kit (AC2553) Quantitative inquiry ASET-1642 Human Laminin ELISA Kit (AC3053) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket